Cantabio Pharmaceuticals Inc (CTBO) - Financial and Strategic SWOT Analysis Review

  • ID: 4284963
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company's pipeline product candidates include CB101 and CB102, used to treat Parkinson’s disease; CB201 is being developing for the treatment of Parkinson’s disease and Alzheimer’s disease and CB301, is used to treat Alzheimer’s disease. Cantabio Pharmaceuticals conducts in house research and development on critical elements of its drug discovery pipeline by utilizing novel technologies and outsourcing generic research activities to contract research organizations. The company has operational presence in Cambridge, the UK and Budapest, Hungary. Cantabio Pharmaceuticals is headquartered in Sunnyvale, California, the US.

Cantabio Pharmaceuticals Inc Key Recent Developments

Sep 13, 2017: Cantabio Pharmaceuticals to Present at 2017 Silicon Valley Bank Healthcare Capital and Connections Summit in Shanghai
Jul 06, 2017: Cantabio Announces Publication of Study Results by University of Cambridge researchers in ACS Chemical Neuroscience

This comprehensive SWOT profile of Cantabio Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cantabio Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Cantabio Pharmaceuticals Inc - Key Information
  • Cantabio Pharmaceuticals Inc - Overview
  • Cantabio Pharmaceuticals Inc - Key Employees
  • Cantabio Pharmaceuticals Inc - Key Employee Biographies
  • Cantabio Pharmaceuticals Inc - Key Operational Heads
  • Cantabio Pharmaceuticals Inc - Major Products and Services
  • Cantabio Pharmaceuticals Inc - History
  • Cantabio Pharmaceuticals Inc - Company Statement
  • Cantabio Pharmaceuticals Inc - Locations And Subsidiaries
  • Cantabio Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cantabio Pharmaceuticals Inc - Business Description
  • Cantabio Pharmaceuticals Inc - Corporate Strategy
  • Cantabio Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cantabio Pharmaceuticals Inc - Strengths
  • Cantabio Pharmaceuticals Inc - Weaknesses
  • Cantabio Pharmaceuticals Inc - Opportunities
  • Cantabio Pharmaceuticals Inc - Threats
  • Cantabio Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cantabio Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cantabio Pharmaceuticals Inc, Key Information
  • Cantabio Pharmaceuticals Inc, Key Ratios
  • Cantabio Pharmaceuticals Inc, Share Data
  • Cantabio Pharmaceuticals Inc, Major Products and Services
  • Cantabio Pharmaceuticals Inc, History
  • Cantabio Pharmaceuticals Inc, Key Employees
  • Cantabio Pharmaceuticals Inc, Key Employee Biographies
  • Cantabio Pharmaceuticals Inc, Key Operational Heads
  • Cantabio Pharmaceuticals Inc, Other Locations
  • Cantabio Pharmaceuticals Inc, Subsidiaries
  • Cantabio Pharmaceuticals Inc, Key Manufacturing facilities
  • Cantabio Pharmaceuticals Inc, Key Competitors
  • Cantabio Pharmaceuticals Inc, SWOT Analysis
  • Cantabio Pharmaceuticals Inc, Ratios based on current share price
  • Cantabio Pharmaceuticals Inc, Annual Ratios
  • Cantabio Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cantabio Pharmaceuticals Inc, Performance Chart
  • Cantabio Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown